Antiretroviral Treatment Failure, Drug resistance and Subtype Diversity in the only Pediatric HIV Clinic in Rhode Island | Zendy

Tanya Rogo | Zendy; Allison DeLong | Zendy; Philip A. Chan | Zendy; Rami Kantor | Zendy

Open Access

Antiretroviral Treatment Failure, Drug resistance and Subtype Diversity in the only Pediatric HIV Clinic in Rhode Island

Author(s) -

Tanya Rogo,

Allison DeLong,

Philip A. Chan,

Rami Kantor

Publication year - 2015

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/civ058

Subject(s) - medicine , formulary , drug resistance , antiretroviral therapy , human immunodeficiency virus (hiv) , antiretroviral treatment , hiv drug resistance , antiretroviral drug , antiretroviral agents , intensive care medicine , population , drug , pediatrics , virology , viral load , family medicine , pharmacology , environmental health , microbiology and biotechnology , biology

Drug resistance development in the human immunodeficiency virus (HIV)-infected pediatric population in the United States can impact long-term antiretroviral therapy (ART) efficacy. Limited formularies and adherence constraints in children jeopardize lifelong-needed ART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research